BYL719

BYL719
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-B9700.1 1 mg -

3 - 8 business days*

83.00€
LKT-B9700.5 5 mg -

3 - 8 business days*

152.00€
LKT-B9700.25 25 mg -

3 - 8 business days*

229.00€
LKT-B9700.100 100 mg -

3 - 8 business days*

589.00€
 
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential... more
Product information "BYL719"
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BYL719 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway.
Keywords: BYL-719
Supplier: LKT Laboratories
Supplier-Nr: B9700

Properties

Application: PI3K inhibitor
MW: 441.47 D
Formula: C19H22F3N5O2S

Database Information

CAS : 1217486-61-7| Matching products
KEGG ID : K00922 | Matching products

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "BYL719"
Write a review
or to review a product.
Viewed